Market Place
Sourcing Support
Nxera Pharma inks deal with Handok to distribute PIVLAZ in South Korea
16 Apr 2024 //
BIOSPECTRUM ASIA
Nxera Announces Exclusive Supply & Distribution Agreement with Handok for PIVLAZ
14 Apr 2024 //
GLOBENEWSWIRE
Sosei Group Announces Marketing Approval for PIVLAZ 150 mg in South Korea
07 Dec 2023 //
GLOBENEWSWIRE
Idorsia announces the results of REACT a Phase 3 study of clazosentan
07 Feb 2023 //
GLOBENEWSWIRE
Idorsia`s PIVLAZ (clazosentan) now available for patients in Japan
20 Apr 2022 //
GLOBENEWSWIRE
The Journal of Neurosurgery reports impact of clazosentan
04 Apr 2022 //
GLOBENEWSWIRE
Idorsia receives Japanese PMDA approval of PIVLAZ (clazosentan sodium) 150 mg
20 Jan 2022 //
GLOBENEWSWIRE
Idorsia submits NDA for clazosentan to Japanese PMDA
01 Mar 2021 //
GLOBENEWSWIRE
Idorsia announces positive results of the two Japanese studies clazosentan
23 Nov 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.